Anthony J. Olszanski
- Oncology top 1%
- Molecular Biology top 5%
- Immunology top 2%
- Pulmonary and Respiratory Medicine top 2%
- Genetics top 5%
- Co-authors
- Thomas F. GajewskiAri M. VanderwaldeIgor PuzanovJonathan CebonLisa ChenAntoni RibasReinhard DummerJohn M. Kirkwood
- Topics
- Cancer Immunotherapy and Biomarkers (51 papers)CAR-T cell therapy research (39 papers)Lung Cancer Treatments and Mutations (26 papers)
- Partner nations
- United StatesCanadaSpain
In The Last Decade
Anthony J. Olszanski
148 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Oncology 2.6k
- Molecular Biology 1.6k
- Immunology 1.3k
- Pulmonary and Respiratory Medicine 848
- Genetics 669
Countries citing papers authored by Anthony J. Olszanski
This map shows the geographic impact of Anthony J. Olszanski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony J. Olszanski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony J. Olszanski more than expected).
Fields of papers citing papers by Anthony J. Olszanski
This network shows the impact of papers produced by Anthony J. Olszanski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony J. Olszanski. The network helps show where Anthony J. Olszanski may publish in the future.
Co-authorship network of co-authors of Anthony J. Olszanski
This figure shows the co-authorship network connecting the top 25 collaborators of Anthony J. Olszanski. A scholar is included among the top collaborators of Anthony J. Olszanski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony J. Olszanski. Anthony J. Olszanski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 7 | |
| 6 | 2 | |
| 7 | 24 | |
| 8 | 5 | |
| 9 | 10 | |
| 10 | 4 | |
| 11 | 58 | |
| 12 | 157 | |
| 13 | 36 | |
| 14 | 5 | |
| 15 | 28 | |
| 16 | 30 | |
| 17 | 24 | |
| 18 | 15 | |
| 19 | Axitinib (AG-013736; AG) in combination with paclitaxel (P)/carboplatin (C) in patients (pts) with advanced solid tumors | 1 |
| 20 | 1 |
About Anthony J. Olszanski
Anthony J. Olszanski is a scholar working on Oncology, Biological Psychiatry and Pulmonary and Respiratory Medicine, having authored 156 papers that have together received 4.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (51 papers), CAR-T cell therapy research (39 papers) and Lung Cancer Treatments and Mutations (26 papers). The work is most often cited by research in Oncology (2.6k citations), Biological Psychiatry (218 citations) and Immunology (1.3k citations). Anthony J. Olszanski has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Thomas F. Gajewski, Ari M. Vanderwalde, Igor Puzanov, Jonathan Cebon, Lisa Chen, Antoni Ribas, Reinhard Dummer, John M. Kirkwood, F. Stephen Hodi and Georgina V. Long. Their work appears in journals such as New England Journal of Medicine, Cell and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.